Incidence and risk factors for community-associated methicillin-resistant Staphylococcus aureus in New York City, 2006-2012

Epidemiology and Infection

Volumn 144, Issue 5, 2016, Pages 1014-1017

  Baker, P ^a   Cohen, B ^a,b   Liu, J ^b   Larson, E ^a,b  

^a Department of Medicine   (United States)

^b Columbia University School of Nursing ^*  (United States)

Author keywords

Methicillin resistant S. aureus (MRSA)

Indexed keywords

AGED; ARTICLE; BACTERIUM ISOLATION; BLOOD CULTURE; COMMUNITY ASSOCIATED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; CONTROLLED STUDY; ELECTRONIC HEALTH RECORD; HOSPITAL ADMISSION; HUMAN; INCIDENCE; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; RISK FACTOR; UNITED STATES; ADOLESCENT; ADULT; COMMUNITY-ACQUIRED INFECTIONS; DRUG EFFECTS; FEMALE; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; NEW YORK; PENICILLIN RESISTANCE; SEASON; STAPHYLOCOCCAL INFECTIONS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ANTIINFECTIVE AGENT; METICILLIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; METHICILLIN; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NEW YORK CITY; RISK FACTORS; SEASONS; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 84941362450     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026881500196X     Document Type: Article

References (12)

1. Boyce JM, et al. Methicillin-resistant Staphylococcus aureus. Lancet Infectious Diseases 2005; 5: 653-663.
2. Mediavilla JR, et al. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Current Opinion in Microbiology 2012; 15: 588-595.
3. Klevens RM, et al. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerging Infectious Diseases 2006; 12: 1991-1993.
4. David MZ, et al. What is community-associated methicillin-resistant Staphylococcus aureus? Journal of Infectious Diseases 2008; 197: 1235-1243.
5. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clinical Infectious Diseases 2003; 36: 131-139.
6. Tacconelli E, et al. Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains. Journal of Antimicrobial Chemotherapy 2004; 53: 474-479.
7. Mera RM, et al. Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion. Microbial Drug Resistance 2011; 17: 321-328.
8. Como-Sabetti K, et al. Community-associated methicillin-resistant Staphylococcus aureus: trends in case and isolate characteristics from six years of prospective surveillance. Public Health Reports 2009; 124: 427-435.
9. Farr AM, et al. Trends in hospitalization for community-associated methicillin-resistant Staphylococcus aureus in New York City, 1997-2006: data from New York State's Statewide Planning and Research Cooperative System. Infection Control and Hospital Epidemiology 2012; 33: 725-731.
10. Apte M, et al. Using electronically available inpatient hospital data for research. Clinical and Translational Science 2011; 4: 338-345.
11. Dukic VM, et al. Epidemics of community-associated methicillin-resistant Staphylococcus aureus in the United States: a meta-analysis. PLoS ONE 2013; 8: e52722.
12. Como-Sabetti KJ, et al. Risk factors for community-associated Staphylococcus aureus infections: results from parallel studies including methicillin-resistant and methicillin-sensitive S. aureus compared to uninfected controls. Epidemiology and Infection 2011; 139: 419-429.